ctrl K

Watchlist Price Alert

CERo Therapeutics Inc. (CERO)

NASDAQ: CERO · Real-Time Price · USD

20.08

13.21 (192.37%)

At close: Jun 17, 2025, 3:59 PM

CERo Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	-0.45	-8.49M	-31.24K	-72.17K
PEG Ratio	-0.00	85.2K	-222.88	n/a
PS Ratio	n/a	n/a	n/a	n/a
PB Ratio	-1.84	-1.52K	8.45K	133.32
P/FCF Ratio	-0.6	-3.72K	-11.67K	-17.39K
P/OCF Ratio	-0.6	-3.72K	-19.1K	-32.67K
OCF/S Ratio	n/a	n/a	n/a	n/a
Debt / Equity Ratio	-0.83	-0.11	0.26	0.02
Quick Ratio	0.50	0.38	1.38	13.88
Current Ratio	0.50	0.38	1.38	13.88
Asset Turnover	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	n/a	n/a
Return on Equity	4.08	n/a	-0.27	n/a
Return on Assets	-1.25	n/a	-0.02	n/a
Return on Invested Capital	47.96	-2.02	-1.71	n/a
Dividend Yield	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a